Search

Your search keyword '"Simons, David"' showing total 1,104 results
Start Over Author "Simons, David"
1,104 results on '"Simons, David"'

3. Digital health at the age of the Anthropocene

Author

Chevance, Guillaume, Hekler, Eric B, Efoui-Hess, Maxime, Godino, Job, Golaszewski, Natalie, Gualtieri, Lisa, Krause, Andrew, Marrauld, Laurie, Nebeker, Camille, Perski, Olga, Simons, David, Taylor, Jennifer C, and Bernard, Paquito

Published
2020

6. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation

Author

Sun, Fiona Yueqian, Villabona-Arenas, C Julian, Nightingale, Emily S, Showering, Alicia, Knight, Gwenan M, Sherratt, Katharine, Liu, Yang, Abbas, Kaja, Funk, Sebastian, Endo, Akira, Hellewell, Joel, Rosello, Alicia, Lowe, Rachel, Quaife, Matthew, Gimma, Amy, Brady, Oliver, Williams, Jack, Procter, Simon R, Eggo, Rosalind M, Chan, Yung-Wai Desmond, Munday, James D, Barnard, Rosanna C, Gore-Langton, Georgia R, Bosse, Nikos I, Waterlow, Naomi R, Diamond, Charlie, Russell, Timothy W, Medley, Graham, Flasche, Stefan, Atkins, Katherine E, Prem, Kiesha, Simons, David, Auzenbergs, Megan, Tully, Damien C, Jarvis, Christopher I, van Zandvoort, Kevin, Abbott, Sam, Pearson, Carl A B, Jombart, Thibaut, Meakin, Sophie R, Foss, Anna M, Kucharski, Adam J, Quilty, Billy J, Gibbs, Hamish P, Clifford, Samuel, Klepac, Petra, Sandmann, Frank G, Davies, Nicholas G, Vassall, Anna, Edmunds, W John, and Jit, Mark

Published
2021
Full Text
View/download PDF

7. Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study

Author

Atkins, Katherine E, Foss, Anna M, Waterlow, Naomi R, Abbas, Kaja, Lowe, Rachel, Pearson, Carl A B, Funk, Sebastian, Rosello, Alicia, Knight, Gwenan M, Bosse, Nikos I, Procter, Simon R, Gore-Langton, Georgia R, Showering, Alicia, Munday, James D, Sherratt, Katharine, Jombart, Thibaut, Nightingale, Emily S, Liu, Yang, Jarvis, Christopher I, Medley, Graham, Brady, Oliver, Gibbs, Hamish P, Simons, David, Williams, Jack, Tully, Damien C, Flasche, Stefan, Meakin, Sophie R, Zandvoort, Kevin, Sun, Fiona Y, Jit, Mark, Klepac, Petra, Quaife, Matthew, Eggo, Rosalind M, Sandmann, Frank G, Endo, Akira, Prem, Kiesha, Abbott, Sam, Barnard, Rosanna, Chan, Yung-Wai D, Auzenbergs, Megan, Gimma, Amy, Villabona-Arenas, C Julian, Davies, Nicholas G, Quilty, Billy J, Clifford, Samuel, Hellewell, Joel, Russell, Timothy W, Kucharski, Adam J, and Edmunds, W John

Published
2021
Full Text
View/download PDF

8. Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study

Author

Emery, Jon C, Medley, Graham, Munday, James D, Russell, Timothy W, Leclerc, Quentin J, Diamond, Charlie, Procter, Simon R, Gimma, Amy, Sun, Fiona Yueqian, Gibbs, Hamish P, Rosello, Alicia, van Zandvoort, Kevin, Hué, Stéphane, Meakin, Sophie R, Deol, Arminder K, Knight, Gwen, Jombart, Thibaut, Foss, Anna M, Bosse, Nikos I, Atkins, Katherine E, Quilty, Billy J, Lowe, Rachel, Prem, Kiesha, Flasche, Stefan, Pearson, Carl A B, Houben, Rein M G J, Nightingale, Emily S, Endo, Akira, Tully, Damien C, Liu, Yang, Villabona-Arenas, Julian, O'Reilly, Kathleen, Funk, Sebastian, Eggo, Rosalind M, Jit, Mark, Rees, Eleanor M, Hellewell, Joel, Clifford, Samuel, Jarvis, Christopher I, Abbott, Sam, Auzenbergs, Megan, Davies, Nicholas G, Simons, David, Kucharski, Adam J, Klepac, Petra, Conlan, Andrew J K, Kissler, Stephen M, Tang, Maria L, Fry, Hannah, Gog, Julia R, and Edmunds, W John

Published
2020
Full Text
View/download PDF

10. Current sampling and sequencing biases of Lassa mammarenavirus limit inference from phylogeography and molecular epidemiology in Lassa fever endemic regions

Author

Arruda, Liã Bárbara, primary, Free, Hayley Beth, additional, Simons, David, additional, Ansumana, Rashid, additional, Elton, Linzy, additional, Haider, Najmul, additional, Honeyborne, Isobella, additional, Asogun, Danny, additional, McHugh, Timothy D., additional, Ntoumi, Francine, additional, Zumla, Alimuddin, additional, and Kock, Richard, additional

Published
2023
Full Text
View/download PDF

12. Spata7 is a retinal ciliopathy gene critical for correct RPGRIP1 localization and protein trafficking in the retina

Author

Eblimit, Aiden, Nguyen, Thanh-Minh T, Chen, Yiyun, Esteve-Rudd, Julian, Zhong, Hua, Letteboer, Stef, Van Reeuwijk, Jeroen, Simons, David L, Ding, Qian, Wu, Ka Man, Li, Yumei, Van Beersum, Sylvia, Moayedi, Yalda, Xu, Huidan, Pickard, Patrick, Wang, Keqing, Gan, Lin, Wu, Samuel M, Williams, David S, Mardon, Graeme, Roepman, Ronald, and Chen, Rui

Subjects
Biochemistry and Cell Biology, Biological Sciences, Eye Disease and Disorders of Vision, Rare Diseases, Pediatric, Orphan Drug, Neurodegenerative, Genetics, Neurosciences, Aetiology, 2.1 Biological and endogenous factors, Eye, Animals, Apoptosis, Cattle, Cytoskeletal Proteins, DNA-Binding Proteins, Gene Deletion, Humans, Mice, Mice, Mutant Strains, Photoreceptor Connecting Cilium, Protein Transport, Proteins, Retinal Cone Photoreceptor Cells, Retinal Rod Photoreceptor Cells, Rhodopsin, Medical and Health Sciences, Genetics & Heredity
Abstract

Leber congenital amaurosis (LCA) and juvenile retinitis pigmentosa (RP) are severe hereditary diseases that causes visual impairment in infants and children. SPATA7 has recently been identified as the LCA3 and juvenile RP gene in humans, whose function in the retina remains elusive. Here, we show that SPATA7 localizes at the primary cilium of cells and at the connecting cilium (CC) of photoreceptor cells, indicating that SPATA7 is a ciliary protein. In addition, SPATA7 directly interacts with the retinitis pigmentosa GTPase regulator interacting protein 1 (RPGRIP1), a key connecting cilium protein that has also been linked to LCA. In the retina of Spata7 null mutant mice, a substantial reduction of RPGRIP1 levels at the CC of photoreceptor cells is observed, suggesting that SPATA7 is required for the stable assembly and localization of the ciliary RPGRIP1 protein complex. Furthermore, our results pinpoint a role of this complex in protein trafficking across the CC to the outer segments, as we identified that rhodopsin accumulates in the inner segments and around the nucleus of photoreceptors. This accumulation then likely triggers the apoptosis of rod photoreceptors that was observed. Loss of Spata7 function in mice indeed results in a juvenile RP-like phenotype, characterized by progressive degeneration of photoreceptor cells and a strongly decreased light response. Together, these results indicate that SPATA7 functions as a key member of a retinal ciliopathy-associated protein complex, and that apoptosis of rod photoreceptor cells triggered by protein mislocalization is likely the mechanism of disease progression in LCA3/ juvenile RP patients.

Published
2015

13. Neutrinos in a left-right model with a horizontal symmetry

Author

Kiers, Ken, Assis, Michael, Simons, David, Petrov, Alexey A., and Soni, Amarjit

Subjects
High Energy Physics - Phenomenology
Abstract

We analyze the lepton sector of a Left-Right Model based on the gauge group SU(2)_L x SU(2)_R x U(1), concentrating mainly on neutrino properties. Using the seesaw mechanism and a horizontal symmetry, we keep the right-handed symmetry breaking scale relatively low, while simultaneously satisfying phenomenological constraints on the light neutrino masses. We take the right-handed scale to be of order 10's of TeV and perform a full numerical analysis of the model's parameter space, subject to experimental constraints on neutrino masses and mixings. The numerical procedure yields results for the right-handed neutrino masses and mixings and the various CP-violating phases. We also discuss phenomenological applications of the model to neutrinoless double beta decay, lepton-flavor-violating decays (including decays such as \tau \to 3\mu) and leptogenesis., Comment: 26 pages, 4 figures

Published
2005
Full Text
View/download PDF

15. Developing transmissible vaccines for animal infections.

Author

Streicker, Daniel G., Griffiths, Megan E., Antia, Rustom, Bergner, Laura, Bowman, Peter, dos Santos de Moraes, Maria Vitoria, Esvelt, Kevin, Famulare, Mike, Gilbert, Amy, He, Biao, Jarvis, Michael A., Kennedy, David A., Kuzma, Jennifer, Wanyonyi, Carolyne Nasimiyu, Remien, Christopher, Rocke, Tonie, Rosenke, Kyle, Schreiner, Courtney, Sheen, Justin, and Simons, David

Published
2024
Full Text
View/download PDF

20. Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England

Author

Allen, Hester, primary, Tessier, Elise, additional, Turner, Charlie, additional, Anderson, Charlotte, additional, Blomquist, Paula, additional, Simons, David, additional, Løchen, Alessandra, additional, Jarvis, Christopher I., additional, Groves, Natalie, additional, Capelastegui, Fernando, additional, Flannagan, Joe, additional, Zaidi, Asad, additional, Chen, Cong, additional, Rawlinson, Christopher, additional, Hughes, Gareth J., additional, Chudasama, Dimple, additional, Nash, Sophie, additional, Thelwall, Simon, additional, Lopez-Bernal, Jamie, additional, Dabrera, Gavin, additional, Charlett, André, additional, Kall, Meaghan, additional, and Lamagni, Theresa, additional

Published
2023
Full Text
View/download PDF

22. Adressen

Author

Bösch, Daniel, primary, Colla, Fernando, additional, Dommerholt, Jan, additional, Gröbli, Christian, additional, Reilich, Peter, additional, Schoser, Benedikt, additional, Simons, David G., additional, Fischer, Christine Stebler, additional, and Weissmann, Richard, additional

Published
2018
Full Text
View/download PDF

30. Towards Temporally-Coherent Video Matting

Author

Bai, Xue, Wang, Jue, Simons, David, Hutchison, David, Series editor, Kanade, Takeo, Series editor, Kittler, Josef, Series editor, Kleinberg, Jon M., Series editor, Mattern, Friedemann, Series editor, Mitchell, John C., Series editor, Naor, Moni, Series editor, Nierstrasz, Oscar, Series editor, Pandu Rangan, C., Series editor, Steffen, Bernhard, Series editor, Sudan, Madhu, Series editor, Terzopoulos, Demetri, Series editor, Tygar, Doug, Series editor, Vardi, Moshe Y., Series editor, Weikum, Gerhard, Series editor, Gagalowicz, André, editor, and Philips, Wilfried, editor

Published
2011
Full Text
View/download PDF

31. Protocol for the association of smoking status with hospitalisation for COVID-19 compared with other respiratory viruses a year previous: A case-control study at a single UK National Health Service trust

Author

Simons, David, Perski, Olga, Brown, Jamie, Shahab, Lion, and Bailey, Robin

Subjects
Epidemiology, Smoking, Medicine and Health Sciences, COVID-19, Diseases, Public Health, Hardware_REGISTER-TRANSFER-LEVELIMPLEMENTATION
Abstract

Pre-registered study protocol and analysis plan

Published
2022
Full Text
View/download PDF

34. The association between smoking, nicotine and SARS-CoV-2 infection in the UK ONS COVID-19 Infection Survey

Author

Perski, Olga, Simons, David, Tattan-Birch, Harry, Beard, Emma, Walker, Ann, Shahab, Lion, and Brown, Jamie

Subjects
cross-sectional, SARS-CoV-2, Medicine and Health Sciences, COVID-19, tobacco smoking, Social and Behavioral Sciences
Abstract

The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, is placing an unprecedented burden on healthcare and social systems in the UK and globally: with community transmission established in February 2020, COVID-19 has led to >9 million infections in the UK, with >140,000 premature deaths as of November 2021. At the start of the pandemic, many researchers and healthcare professionals hypothesised that tobacco smoking would be a risk factor for SARS-CoV-2 infection and subsequent disease progression. This was based on prior knowledge of biological, social, and behavioural factors that increase the risk of viral transmission. First, SARS­CoV­2 enters epithelial cells through the angiotensin-converting enzyme 2 (ACE­2) receptor, with evidence suggesting that gene expression and subsequent receptor levels are elevated in smokers, thus potentially putting smokers at higher risk of contracting SARS­CoV­2 if exposed to the virus. However, reduced receptor levels in smokers have also been reported. Second, both current and former smoking increase the risk of other respiratory viral and bacterial infections. Third, behavioural factors involved in smoking (e.g. regular hand-to-mouth movements) may increase SARS­CoV­2 infection through increased exposure and onward transmission once infected. Fourth, individuals from lower (compared with higher) socioeconomic position (SEP) groups are more likely to be smokers and are also more likely to live in overcrowded housing and/or be employed in occupations with increased viral exposure (e.g., supermarkets, warehouses, public transport). If smoking confers an increased risk of infection, this would further emphasise the need for public health efforts to support smoking cessation, with campaigns potentially leveraging motivation to quit to protect oneself and others from COVID-19. We aim to examine, in the nationally representative UK Office for National Statistics (ONS) COVID-19 Infection Survey, whether 1) current vs. never smoking is associated with reduced risk of a) testing positive for SARS-CoV-2; and b) SARS-CoV-2 seropositivity; 2) former vs. never smoking is associated with increased risk of a) testing positive for SARS-CoV-2; and b) SARS-CoV-2 seropositivity; 3) among nicotine users, current cigarette smoking vs. no cigarette smoking is associated with equivocal risk of a) testing positive for SARS-CoV-2; and b) SARS-CoV-2 seropositivity; 4) among former and never smokers, e-cigarette use vs. no e-cigarette is associated with reduced risk of a) testing positive for SARS-CoV-2; and b) SARS-CoV-2 seropositivity; 5) for the above questions, whether associations vary over the course of the pandemic; and 6) in those testing positive for SARS-CoV-2, current smoking/nicotine use is associated with a) greater mean PCR cycle threshold values; and b) a lower number of self-reported symptoms.

Published
2022
Full Text
View/download PDF

36. Community transmission of monkeypox in the United Kingdom, April to May 2022

Author

Vivancos, Roberto, Anderson, Charlotte, Blomquist, Paula, Balasegaram, Sooria, Bell, Anita, Bishop, Louise, Brown, Colin S, Chow, Yimmy, Edeghere, Obaghe, Florence, Isaac, Logan, Sarah, Manley, Petra, Crowe, William, McAuley, Andrew, Shankar, Ananda Giri, Mora-Peris, Borja, Paranthaman, Karthik, Prochazka, Mateo, Ryan, Cian, Simons, David, Vipond, Richard, Byers, Chloe, Watkins, Nicholas A, UKHSA Monkeypox Incident Management team, Welfare, Will, Whittaker, Elizabeth, Dewsnap, Claire, Wilson, Allegra, Young, Yvonne, Chand, Meera, Riley, Steven, Hopkins, Susan, and Monkeypox Incident Management Team

Abstract

Between 7 and 25 May, 86 monkeypox cases were confirmed in the United Kingdom (UK). Only one case is known to have travelled to a monkeypox virus (MPXV) endemic country. Seventy-nine cases with information were male and 66 reported being gay, bisexual, or other men who have sex with men. This is the first reported sustained MPXV transmission in the UK, with human-to-human transmission through close contacts, including in sexual networks. Improving case ascertainment and onward-transmission preventive measures are ongoing.

Published
2022

38. Lassa fever cases suffer from severe underreporting based on reported fatalities.

Author

Simons, David

Subjects
*LASSA fever, *HEMORRHAGIC fever, *LITERATURE reviews, *NEGLECTED diseases, *DEATH rate, *PARACOCCIDIOIDOMYCOSIS
Abstract

Background Lassa fever is a viral haemorrhagic fever endemic to eight West African countries. Symptomatic disease is expected to occur in 20% of those infected and transmission typically occurs from viral spillover from rodent hosts. The combination of limited access to diagnostics and healthcare means the true burden of this disease is unknown. Methods The case fatality rate among confirmed, probable and possible cases of Lassa fever in endemic regions is expected to be ≈15%. Here, annual reported cases and deaths have been used to estimate the case fatality rate, using three subsets of available data, to understand the scale of underreporting of severe human cases. Results The literature review produced 38 records of cases and fatalities, comprising 5230 reported cases and 1482 reported deaths in seven countries. The estimated case fatality rate ranges from 16.5 to 25.6% (standard deviation 11.5–32.2). The expected number of severe cases between 2012 and 2022 is 8995, with current reported numbers 58% of what is expected. Conclusion This analysis highlights current uncertainty and systemic underreporting of the morbidity and mortality burden of Lassa fever in its endemic region and must be considered when discussing the epidemiology of this neglected tropical disease. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

43. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

Author

Andrews, Nick, primary, Stowe, Julia, additional, Kirsebom, Freja, additional, Toffa, Samuel, additional, Rickeard, Tim, additional, Gallagher, Eileen, additional, Gower, Charlotte, additional, Kall, Meaghan, additional, Groves, Natalie, additional, O’Connell, Anne-Marie, additional, Simons, David, additional, Blomquist, Paula B., additional, Zaidi, Asad, additional, Nash, Sophie, additional, Iwani Binti Abdul Aziz, Nurin, additional, Thelwall, Simon, additional, Dabrera, Gavin, additional, Myers, Richard, additional, Amirthalingam, Gayatri, additional, Gharbia, Saheer, additional, Barrett, Jeffrey C., additional, Elson, Richard, additional, Ladhani, Shamez N., additional, Ferguson, Neil, additional, Zambon, Maria, additional, Campbell, Colin N.J., additional, Brown, Kevin, additional, Hopkins, Susan, additional, Chand, Meera, additional, Ramsay, Mary, additional, and Lopez Bernal, Jamie, additional

Published
2022
Full Text
View/download PDF

44. Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data, England, 15 November to 31 December 2021

Author

Blomquist, Paula B, primary, Bridgen, Jessica, additional, Bray, Neil, additional, O’Connell, Anne Marie, additional, West, Daniel, additional, Groves, Natalie, additional, Gallagher, Eileen, additional, Utsi, Lara, additional, Jarvis, Christopher I, additional, Hardstaff, Jo L, additional, Byers, Chloe, additional, Metelmann, Soeren, additional, Simons, David, additional, Zaidi, Asad, additional, Twohig, Katherine A, additional, Savagar, Bethan, additional, Løchen, Alessandra, additional, Ryan, Cian, additional, Wrenn, Katie, additional, Saavedra-Campos, María, additional, Abedin, Zahidul, additional, Florence, Isaac, additional, Cleary, Paul, additional, Elson, Richard, additional, Vivancos, Roberto, additional, and Lake, Iain R, additional

Published
2022
Full Text
View/download PDF

45. The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)

Author

Simons, David, Shahab, Lion, Brown, Jamie, and Perski, Olga

Subjects
Risk, Nicotine, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), living review, MEDLINE, Reviews, 030508 substance abuse, Medicine (miscellaneous), Review, Disease, Electronic Nicotine Delivery Systems, Severity of Illness Index, tobacco, SARS‐CoV‐2, nicotine replacement therapy, 03 medical and health sciences, 0302 clinical medicine, Disease severity, COVID‐19, Severity of illness, Prevalence, Credible interval, Humans, Medicine, 030212 general & internal medicine, e‐cigarettes, hospitalisation, SARS-CoV-2, business.industry, Smoking, COVID-19, Bayes Theorem, Former Smoker, Nicotine replacement therapy, mortality, infection, Hospitalization, Psychiatry and Mental health, Relative risk, Smoking status, Observational study, Public Health, 0305 other medical science, business, Demography
Abstract

Aims: To estimate the association of smoking status with rates of i) infection, ii) hospitalisation, iii) disease severity in hospitalised patients, and iv) mortality from SARS-CoV-2/COVID-19 disease. Design: Living rapid review of observational and experimental studies with random-effects hierarchical Bayesian meta-analyses. Published articles and pre-prints were identified via MEDLINE and medRxiv.Setting: Community or hospital. No restrictions on location. Participants: Adults who received a SARS-CoV-2 test or a COVID-19 diagnosis. Measurements: Outcomes were SARS-CoV-2 infection, hospitalisation, disease severity and mortality stratified by smoking status. Study quality was assessed (i.e. ‘good,’ ‘fair’ and ‘poor’). Findings: v12 (searches up to 2021-07-18) included 547 studies with 87 ‘good’ and ‘fair’ quality studies included in unadjusted meta-analyses. 171 studies (31.3%) reported current, former and never smoking status with the remainder using broader categories. Recorded smoking prevalence among people with COVID-19 was generally lower than national prevalence. Current compared with never smokers were at reduced risk of SARS-CoV-2 infection (RR = 0.67, 95% Credible Interval (CrI) = 0.60-0.75, τ = 0.27). Data for former smokers were inconclusive (RR = 0.99, 95% CrI = 0.94-1.05, τ = 0.12) but favoured there being no important association (

Published
2020

48. Smoking, Nicotine, and COVID-19: Triangulation of Methods and Preregistration Are Required for Robust Causal Inference.

Author

Perski, Olga, Simons, David, Shahab, Lion, and Brown, Jamie

Subjects
*CAUSAL inference, *NICOTINE, *COVID-19, *TRIANGULATION, *NICOTINIC acetylcholine receptors, *CORONAVIRUS diseases
Abstract

Google Scholar PubMed OpenURL Placeholder Text WorldCat 7 Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Figure 1 presents two of these, the first from smoking and/or nicotine to SARS-CoV-2 infection (panel A) and the second, once infected, from smoking and/or nicotine to severe disease and death (panel B). A recent collection of articles in I Nicotine & Tobacco Research i ,[1] dedicated to the potential adverse or protective effects of smoking and/or nicotine use on COVID-19 outcomes, highlighted a priori biological and behavioral reasons as to why smoking status may be expected to influence COVID-19 infection, disease severity, and mortality.[2],[3] For example, SARS-CoV-2 gains cell entry via the ACE-2 receptor, with elevated ACE-2 receptor levels observed in tobacco smokers - although reduced levels have also been reported.[4] At the same time, nicotine is an agonist of the cholinergic anti-inflammatory pathway, which may protect against a hyperinflammatory response to the virus, potentially preventing severe disease and/or mortality in smokers and/or nicotine users.[5] On the other hand, smoking causes respiratory and cardiovascular diseases that are associated with worse COVID-19 outcomes.[6] However, it was concluded that we currently have "more questions than answers", with a need for additional, high-quality research.[[1], [3]] More than a year into the COVID-19 pandemic and several months since the publication of the abovementioned article collection, answers are still few and far between. [Extracted from the article]

Published
2023
Full Text
View/download PDF

50. Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England

Author

Allen, Hester, primary, Tessier, Elise, additional, Turner, Charlie, additional, Anderson, Charlotte, additional, Blomquist, Paula, additional, Simons, David, additional, Løchen, Alessandra, additional, Jarvis, Christopher I, additional, Groves, Natalie, additional, Capelastegui, Fernando, additional, Flannagan, Joe, additional, Zaidi, Asad, additional, Chen, Cong, additional, Rawlinson, Christopher, additional, Hughes, Gareth J., additional, Chudasama, Dimple, additional, Nash, Sophie, additional, Thelwall, Simon, additional, Lopez-Bernal, Jamie, additional, Dabrera, Gavin, additional, Charlett, André, additional, Kall, Meaghan, additional, and Lamagni, Theresa, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results